Business Matters: Personalized Medicine or Blockbusterology?
April 15, 2002
G. Steven BurrillG. Steven Burrill
Chief Executive Officer at Burrill & Company
BioPharm International, BioPharm International-04-01-2002, Volume 15, Issue 4
by G. Steven Burrill, Burrill & Company Biotechnology offers to change the face of medicine, if big pharma doesn't stand in the way